{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:46:17Z","timestamp":1778154377451,"version":"3.51.4"},"reference-count":36,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: This study aims to evaluate the long-term efficacy and safety of ab interno techniques using minimally invasive glaucoma surgery (MIGS), specifically XEN gel stent implantation, by evaluating its 2-year outcomes in patients with primary open-angle glaucoma (POAG) and pseudoexfoliation glaucoma (PXG). Methods: This retrospective single-center study consecutively included 31 eyes of 31 patients with POAG or PXG who underwent XEN gel stent implantation. Patients were followed for 24 months, with assessments at multiple time points. Success was defined as achieving an IOP of less than 14 mmHg and a reduction of more than 20% from preoperative IOP without additional glaucoma surgery. Bleb morphology was evaluated using anterior segment optical coherence tomography (AS-OCT) and slit-lamp photographs. Postoperative interventions and complications were also recorded. Results: At 24 months, complete success and qualified success rates were 35.5% (11\/31) and 51.6% (16\/31), respectively. There was no difference in surgical success rates at 2 years based on the tip location (intraconjunctiva, intratenon, and uviform) on the 1st postoperative day. Patients with high sparse wall on AS-OCT imaging or avascular bleb morphology via slit-lamp photography at 6 months postoperatively had higher complete success rates at 2 years than those without (p = 0.007, p = 0.009, respectively). Patients with avascular bleb types at 6 months postoperatively had higher qualified success rates at 2 years compared with the vascular types (p = 0.038). Needling was performed in 32.3% of eyes, with secondary surgical procedures required in 16.1% of eyes. The most common adverse event was hypotony, occurring in 67.7% of eyes on the 1st postoperative day but resolving within 6 months. Conclusions: The ab interno XEN gel stent is an effective and minimally invasive option for managing POAG and PXG, with long-term success predicted by the AS-OCT assessment of bleb morphology at 6 months. Proactive postoperative management, emphasizing early intervention and monitoring, is crucial for maintaining optimal outcomes.<\/jats:p>","DOI":"10.3390\/jcm14134617","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T13:06:17Z","timestamp":1751288777000},"page":"4617","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surgical Outcomes of XEN45 Gel Stent Using Ab Interno Technique in Open-Angle Glaucoma: A 2-Year Follow-Up Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Doah","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam 13496, Gyeonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myungjin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam 13496, Gyeonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin","family":"Lee","sequence":"additional","affiliation":[{"name":"Allbarun Eye Clinic, Suwon 16499, Gyeonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9520-4089","authenticated-orcid":false,"given":"Seungsoo","family":"Rho","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam 13496, Gyeonggi-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jcrs.2014.01.032","article-title":"Ab interno approach to the subconjunctival space using a collagen glaucoma stent","volume":"40","author":"Lewis","year":"2014","journal-title":"J. Cataract. Refract. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/ICU.0000000000000928","article-title":"Results from the Primary Tube Versus Trabeculectomy Study and translation to clinical practice","volume":"34","author":"Gedde","year":"2023","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ogla.2021.03.012","article-title":"Trends and Usage Patterns of Minimally Invasive Glaucoma Surgery in the United States: IRIS\u00ae Registry Analysis 2013\u20132018","volume":"4","author":"Yang","year":"2021","journal-title":"Ophthalmol. Glaucoma"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4103\/2008-322X.170343","article-title":"The Future of Glaucoma Surgery","volume":"10","author":"Sheybani","year":"2015","journal-title":"J. Ophthalmic. Vis. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e000830","DOI":"10.1136\/bmjophth-2021-000830","article-title":"Trabeculectomy versus Xen gel implant for the treatment of open-angle glaucoma: A 3-year retrospective analysis","volume":"7","author":"Cappelli","year":"2022","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chen, X.Z., Liang, Z.Q., Yang, K.Y., Lv, K., Ma, Y., Li, M.Y., and Wu, H.J. (2022). The Outcomes of XEN Gel Stent Implantation: A Systematic Review and Meta-Analysis. Front. Med., 9.","DOI":"10.3389\/fmed.2022.804847"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/IJG.0000000000001430","article-title":"Impact of Phacoemulsification Combined with XEN Gel Stent Implantation on Corneal Endothelial Cell Density: 2-Year Results","volume":"29","author":"Gillmann","year":"2020","journal-title":"J. Glaucoma"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/IJG.0000000000001840","article-title":"Endothelial Cell Density After XEN Implant Surgery: Short-term Data from the Italian XEN Glaucoma Treatment Registry (XEN-GTR)","volume":"30","author":"Oddone","year":"2021","journal-title":"J. Glaucoma"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/aos.14627","article-title":"Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma","volume":"99","author":"Rauchegger","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/eye.2017.162","article-title":"One-year result of XEN45 implant for glaucoma: Efficacy, safety, and postoperative management","volume":"32","author":"Tan","year":"2018","journal-title":"Eye"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/IJG.0000000000002302","article-title":"XEN45 gel stent implantation in open-angle glaucoma: 5-year results of a prospective study","volume":"32","author":"Torbey","year":"2023","journal-title":"J. Glaucoma"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10792-021-02069-5","article-title":"A retrospective review of XEN implant surgery: Efficacy, safety and the effect of combined cataract surgery","volume":"42","author":"Nicolaou","year":"2022","journal-title":"Int. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00417-017-3895-3","article-title":"MIGS: Therapeutic success of combined Xen Gel Stent implantation with cataract surgery","volume":"256","author":"Hohberger","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41433-018-0243-8","article-title":"A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery","volume":"33","author":"Karimi","year":"2019","journal-title":"Eye"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/1120672120924339","article-title":"XEN Gel Stent versus trabeculectomy: Short-term effects on corneal endothelial cells","volume":"31","author":"Olgun","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/IJG.0000000000002090","article-title":"3-Year outcomes of XEN implant compared with trabeculectomy, with or without phacoemulsification for open-angle glaucoma","volume":"31","year":"2022","journal-title":"J. Glaucoma"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1167\/tvst.11.2.26","article-title":"Bleb Analysis Using Anterior Segment Optical Coherence Tomography and Surgical Predictors of XEN Gel Stent","volume":"11","author":"Kim","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wy, S., Shin, Y.I., Kim, Y.K., Jeoung, J.W., and Park, K.H. (2023). Bleb Morphology on Anterior-Segment Optical Coherence Tomography after XEN Gel Stent Implantation. J. Clin. Med., 12.","DOI":"10.3390\/jcm12216740"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/IJG.0000000000002208","article-title":"Short-Term Outcomes of Xen-45 Gel Stent Ab Interno Versus Ab Externo Transconjunctival Approaches","volume":"32","author":"Yuan","year":"2023","journal-title":"J. Glaucoma"},{"key":"ref_20","first-page":"e231","article-title":"Longitudinal bleb morphology in anterior segment OCT after minimally invasive transscleral ab interno Glaucoma Gel Microstent implantation","volume":"97","author":"Lenzhofer","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1136\/bjo-2023-325077","article-title":"Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: Real-world data from the Fight Glaucoma Blindness registry","volume":"108","author":"Arnould","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00417-019-04251-z","article-title":"Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma","volume":"257","author":"Reitsamer","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajo.2017.07.023","article-title":"Performance and Safety of a New Ab Interno Gelatin Stent in Refractory Glaucoma at 12 Months","volume":"183","author":"Grover","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ogla.2019.03.011","article-title":"Two-Year Outcomes of XEN Gel Stent Surgery in Patients with Open-Angle Glaucoma","volume":"2","author":"Mansouri","year":"2019","journal-title":"Ophthalmol. Glaucoma"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/IJG.0000000000001295","article-title":"XEN Gel Stent in Pseudoexfoliative Glaucoma: 2-Year Results of a Prospective Evaluation","volume":"28","author":"Gillmann","year":"2019","journal-title":"J. Glaucoma"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1177\/1120672120963447","article-title":"Needling after XEN gel implant: What\u2019s the efficacy? A 1-year analysis","volume":"31","author":"Jose","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/IJG.0000000000001394","article-title":"Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study","volume":"29","author":"Midha","year":"2020","journal-title":"J. Glaucoma"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bjophthalmol-2019-313870","article-title":"Efficacy and safety data for the XEN45 implant at 2 years: A retrospective analysis","volume":"104","author":"Gabbay","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref_29","first-page":"2649","article-title":"Does mitomycin-C concentration have any influence on XEN45 gel stent outcomes in a real-world setting?","volume":"260","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1055\/a-1384-1020","article-title":"Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients","volume":"238","author":"Denkel","year":"2021","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.survophthal.2020.05.005","article-title":"Learning from the past: Mitomycin C use in trabeculectomy and its application in bleb-forming minimally invasive glaucoma surgery","volume":"66","author":"Bell","year":"2021","journal-title":"Surv. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Baeg, J.Y., Choi, H.S., and Lee, S.H. (2023). A case of mitomycin C toxicity after XEN gel stent implantation with the XEN air technique in a glaucoma patient. BMC Ophthalmol., 23.","DOI":"10.1186\/s12886-023-03152-4"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/IJG.0000000000000803","article-title":"Ab Interno Gel Implant for the Treatment of Glaucoma Patients with or Without Prior Glaucoma Surgery: 1-Year Results","volume":"26","author":"Hengerer","year":"2017","journal-title":"J. Glaucoma"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00417-020-04654-3","article-title":"XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes","volume":"258","author":"Bravetti","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/OPTH.S405821","article-title":"Long-Term Effectiveness of XEN 45 Gel-Stent in Open-Angle Glaucoma Patients","volume":"17","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s40123-024-00917-y","article-title":"Swiss Multicenter Ab Interno XEN45 Gel Stent Study: 2-Year Real-World Data","volume":"13","author":"Papazoglou","year":"2024","journal-title":"Ophthalmol. Ther."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/13\/4617\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:01:34Z","timestamp":1760032894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/13\/4617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":36,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["jcm14134617"],"URL":"https:\/\/doi.org\/10.3390\/jcm14134617","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}